Form 8-K - Current report:
SEC Accession No. 0001628280-25-022734
Filing Date
2025-05-06
Accepted
2025-05-06 16:38:55
Documents
16
Period of Report
2025-04-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K natr-20250430.htm   iXBRL 8-K 46641
2 EX-99.1 natrq12025earningsrelease.htm EX-99 204465
6 image.jpg GRAPHIC 8667
7 GRAPHIC natr-20250430_g1.jpg GRAPHIC 117340
  Complete submission text file 0001628280-25-022734.txt   694929

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT natr-20250430.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT natr-20250430_lab.xml EX-101.LAB 20770
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT natr-20250430_pre.xml EX-101.PRE 11993
18 EXTRACTED XBRL INSTANCE DOCUMENT natr-20250430_htm.xml XML 2645
Mailing Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043
Business Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043 (801) 341-7900
NATURES SUNSHINE PRODUCTS INC (Filer) CIK: 0000275053 (see all company filings)

EIN.: 870327982 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34483 | Film No.: 25917904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)